Literature DB >> 4102059

L-dopa as a vitamin-B6 antagonist.

D F Evered.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 4102059     DOI： 10.1016/s0140-6736(71)92480-9

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  4 in total

1.  Serum pyridoxal in patients with gastric pathology.

Authors:  C R Sanderson; R E Davis
Journal:  Gut       Date:  1976-05       Impact factor: 23.059

Review 2.  Levodopa: a review of its pharmacological properties and therapeutic use with particular reference to Parkinsonism.

Authors:  R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1971       Impact factor: 9.546

3.  Pyridoxal 5'-phosphate in cerebrospinal fluid; factors affecting concentration.

Authors:  Emma J Footitt; Simon J Heales; Philippa B Mills; George F G Allen; Marcus Oppenheim; Peter T Clayton
Journal:  J Inherit Metab Dis       Date:  2011-02-09       Impact factor: 4.982

4.  Serum pyridoxal in active peptic ulceration.

Authors:  C R Sanderson; R E Davis
Journal:  Gut       Date:  1975-03       Impact factor: 23.059
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.